The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain Medicine Meeting Receive President's Choice Award
CLEVELAND, Nov. 18, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics has been honored with three President’s Choice Abstract Awards at the 20th Annual ASRA Pain Medicine Meeting taking place November 18-20 in San Francisco. All three presentations feature studies that highlight the ongoing, successful application of percutaneous peripheral nerve stimulation (PNS) with the SPRINT® PNS System for the treatment of chronic pain.
Only 26 of the 300 abstracts accepted were awarded President’s Choice selections. With three selections, SPR Therapeutics studies account for over ten percent of all President’s Choice honorees.
The selected abstracts detail:
Adoption of the SPRINT PNS System has more than doubled in the past year, having been used to treat over 7,000 patients to date by physicians seeking a pain management solution that does not rely on the use of opioids, tissue destruction, or require a permanent implant.
SPR Therapeutics will be at the ASRA Fall meeting and hosting a live, moderate breakfast symposium entitled “The Percutaneous PNS Trifecta: Clinician Experts, New Findings and Practical Applications” on Saturday, November 20. The session will be moderated by Dr. David Dickerson in addition to Dr. Mehul Desai, Dr. Ramo Naidu and Dr. Matthew Pingree who will present study findings.
About the SPRINT® PNS System
The SPRINT PNS System is indicated for up to 60 days for: Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; Symptomatic relief of post-traumatic pain; Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the region innervated by the cranial and facial nerves.
For additional information regarding safety and efficacy, visit www.SprintPNS.com.
About SPR Therapeutics, Inc.
More information can be found at www.SPRTherapeutics.com.
SPR Contacts: Mark Stultz Senior Vice President [email protected] 612.770.0390 Dave Folkens Public Relations Contact [email protected] 612.978.6547
CannTech Expo Exhibit Hall Open
Strategies for Enabling Effective Remote Work
ITEXPO #TECHSUPERSHOW Networking Live Party